Canada markets close in 2 hours 35 minutes

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.1800-0.0200 (-1.67%)
As of 01:24PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
59,654
65,494
47,638
38,350
62,898
Cost of Revenue
22,499
22,982
19,592
16,349
10,873
Gross Profit
37,155
42,512
28,046
22,001
52,025
Operating Expenses
Research Development
14,133
17,093
29,349
29,734
38,167
Selling General and Administrative
14,959
14,959
11,711
12,729
11,148
Total Operating Expenses
29,092
32,052
41,060
42,463
49,315
Operating Income or Loss
8,063
10,460
-13,014
-20,462
2,710
Interest Expense
2,921
3,180
2,529
7,521
9,671
Income Before Tax
6,769
8,566
-14,397
-27,582
-6,523
Income Tax Expense
-79
254
530
0
-
Income from Continuing Operations
6,848
8,312
-14,927
-27,582
-6,523
Net Income
6,848
8,312
-14,927
-27,582
-6,523
Net Income available to common shareholders
6,848
8,312
-14,927
-27,582
-6,523
Basic EPS
0.15
0.12
-0.31
-0.62
-0.22
Diluted EPS
0.09
0.09
-0.31
-0.62
-0.22
Basic Average Shares
62,144
67,513
48,472
44,140
29,148
Diluted Average Shares
73,565
82,424
48,472
44,140
29,148